Lrrk2 R1441 substitution and progressive supranuclear palsy

被引：33

作者：

Ross, OA

Whittle, AJ

Cobb, SA

Hulihan, MM

Lincoln, SJ

Toft, M

Farrer, MJ

Dickson, DW

机构：

[1] Mayo Clin Jacksonville, Dept Neurosci, Coll Med, Jacksonville, FL 32224 USA

[2] Mayo Clin Jacksonville, Dept Pathol, Coll Med, Jacksonville, FL 32224 USA

来源：

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY | 2006年 / 32卷 / 01期

关键词：

Lrrk2; neurodegeneration; PSP;

D O I：

10.1111/j.1365-2990.2006.00693.x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Mutation of the LRRK2 gene has been associated with autosomal dominant parkinsonism. An R1441C pathogenic substitution was identified in Family D, a large Western Nebraskan kindred, with four members demonstrating pleomorphic pathology at autopsy. One member of this family displayed tau pathology suggestive of progressive supranuclear palsy (PSP). To evaluate the influence of mutation at the R1441 residue in this disorder we screened a series of 242 pathologically confirmed PSP cases. No evidence was found for the presence of a mutation at this codon in our series. These data would suggest that this Lrrk2 variant does not contribute in susceptibility to PSP.

引用

页码：23 / 25

页数：3

共 20 条

[1] Multiple regions contribute to membrane targeting of Rab GTPases [J].

Ali, BR ;

Wasmeier, C ;

Lamoreux, L ;

Strom, M ;

Seabra, MC .

JOURNAL OF CELL SCIENCE, 2004, 117 (26) :6401-6412

[2] Association of an extended haplotype in the tau gene with progressive supranuclear palsy [J].

Baker, M ;

Litvan, I ;

Houlden, H ;

Adamson, J ;

Dickson, D ;

Perez-Tur, J ;

Hardy, J ;

Lynch, T ;

Bigio, E ;

Hutton, M .

HUMAN MOLECULAR GENETICS, 1999, 8 (04) :711-715

[3] Roc, a Ras/GTPase domain in complex proteins [J].

Bosgraaf, L ;

Van Haastert, PJM .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2003, 1643 (1-3) :5-10

[4] Genetic evidence for the involvement of tau in progressive supranuclear palsy [J].

Conrad, C ;

Andreadis, A ;

Trojanowski, JQ ;

Dickson, DW ;

Kang, D ;

Chen, XH ;

Wiederholt, W ;

Hansen, L ;

Masliah, E ;

Thal, LJ ;

Katzman, R ;

Xia, Y ;

Saitoh, T .

ANNALS OF NEUROLOGY, 1997, 41 (02) :277-281

[5]

Di Fonzo A, 2005, LANCET, V365, P412

[6] Common LRRK2 mutation in idiopathic Parkinson's disease [J].

Gilks, WP ;

Abou-Sleiman, PM ;

Gandhi, S ;

Jain, S ;

Singleton, A ;

Lees, AJ ;

Shaw, K ;

Bhatia, KP ;

Bonifati, V ;

Quinn, NP ;

Lynch, J ;

Healy, DG ;

Holton, JL ;

Revesz, T ;

Wood, NW .

LANCET, 2005, 365 (9457) :415-416

[7] PRELIMINARY NINDS NEUROPATHOLOGIC CRITERIA FOR STEELE-RICHARDSON-OLSZEWSKI SYNDROME (PROGRESSIVE SUPRANUCLEAR PALSY) [J].

HAUW, JJ ;

DANIEL, SE ;

DICKSON, D ;

HOROUPIAN, DS ;

JELLINGER, K ;

LANTOS, PL ;

MCKEE, A ;

TABATON, M ;

LITVAN, I .

NEUROLOGY, 1994, 44 (11) :2015-2019

[8] Diagnostic accuracy of progressive supranuclear palsy in the society for progressive supranuclear palsy brain bank [J].

Josephs, KA ;

Dickson, DW .

MOVEMENT DISORDERS, 2003, 18 (09) :1018-1026

[9] Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism:: Evidence of a common founder across European populations [J].

Kachergus, J ;

Mata, IF ;

Hulihan, M ;

Taylor, JP ;

Lincoln, S ;

Aasly, J ;

Gibson, JM ;

Ross, OA ;

Lynch, T ;

Wiley, J ;

Payami, H ;

Nutt, J ;

Maraganore, DM ;

Czyzewski, K ;

Styczynska, M ;

Wszolek, ZK ;

Farrer, MJ ;

Toft, M .

AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 76 (04) :672-680

[10] Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) [J].

Litvan, I ;

Agid, Y ;

Jankovic, J ;

Goetz, C ;

Brandel, JP ;

Lai, EC ;

Wenning, G ;

DOlhaberriague, L ;

Verny, M ;

Chaudhuri, KR ;

McKee, A ;

Jellinger, K ;

Bartko, JJ ;

Mangone, CA ;

Pearce, RKB .

NEUROLOGY, 1996, 46 (04) :922-930

← 1 2 →